SBC-115337

CAS No. 423148-46-3

SBC-115337( —— )

Catalog No. M24388 CAS No. 423148-46-3

SBC-115337 is a PCSK9 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 141 In Stock
10MG 216 In Stock
25MG 372 In Stock
50MG 498 In Stock
100MG 681 In Stock
200MG 917 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SBC-115337
  • Note
    Research use only, not for human use.
  • Brief Description
    SBC-115337 is a PCSK9 inhibitor.
  • Description
    SBC-115337 is a PCSK9 inhibitor.
  • In Vitro
    The potent compound (SBC-115,337) shows an IC50 of 0.6 μM measured in an in vitro ELISA assay to monitor the effect of PCSK9 binding to the recombinant LDLR. SBC-115,337 at 1.2 μM induces more than tenfold upregulation of LDLR in HepG2 cells with respect to the control, increases uptake of fluorescently labeled DiI-LDL and loweres LDL-c levels in mice fed a high-fat diet.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PSCK9
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    423148-46-3
  • Formula Weight
    473.48
  • Molecular Formula
    C29H19N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 6mg/mL?(12.67mM;ultrasonic and warming and heat to 60℃)
  • SMILES
    O=C(C1=CC2=CC=CC=C2O1)NC3=CC=C(C(NC4=CC=C(C5=NC6=CC=CC=C6O5)C=C4)=O)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lavecchia A , Cerchia C . Recent advances in developing PCSK9 inhibitors for lipid-lowering therapy[J]. Future medicinal chemistry, 2019, 11(5):423-441.
molnova catalog
related products
  • IMM-01

    IMM-01 is a novel class of small-molecule agonists of the mammalian Diaphanous (mDia)-related formins, which act downstream of Rho GTPases to assemble actin filaments, and their organization with microfilaments to establish and maintain cell polarity during migration and asymmetric division.

  • 2-Oxobutyric acid

    2-Ketobutyric acid is a product of the lysis of cystathionine. It is also one of the degradation products of threonine. It can be converted into propionyl-CoA and thus enter the citric acid cycle.

  • 4-Hydroxyisoleucine

    4-Hydroxyisoleucine has antidepressant-like antidyslipidemic and antihyperglycemic effects.?It displays an insulinotropic activity.